Search

Search Constraints

You searched for: Author/Creator Liu, Xueke

Search Results

18. Resistance of hepatocellular carcinoma to sorafenib can be overcome with co-delivery of PI3K/mTOR inhibitor BEZ235 and sorafenib in nanoparticles. (2nd April 2020)

19. RETRACTED ARTICLE: Trastuzumab-modified DM1-loaded nanoparticles for HER2+ breast cancer treatment: an in vitro and in vivo study. (17th November 2018)